The research, made available as a peer-reviewed accepted article with a permanent DOI, identifies integrin subunit alpha 5, or ITGA5, as a regulator of endothelial mitochondrial quality control under diabetic conditions. According to the authors, ITGA5 was significantly downregulated in clinical diabetic foot ulcer tissues compared with normal skin tissues, and restoring it accelerated wound closure in a diabetic mouse model.
The clinical starting point was straightforward: the team analyzed ITGA5 expression in diabetic foot ulcer tissues and normal skin samples and found the protein markedly reduced in the wounds. That observation set up the central question of the study, namely whether the loss of ITGA5 contributes to the impaired angiogenesis and persistent endothelial dysfunction that characterize diabetic wounds, both of which have been linked to mitochondrial dysfunction.
To test the idea, the researchers used a db/db diabetic mouse wound model in which they delivered lentiviral ITGA5 overexpression. The treated animals showed faster wound closure, improved collagen organization, and enhanced angiogenesis, together with increased ITGA5 and CD31-positive vascular signals at the wound site. These results indicate that boosting ITGA5 in diabetic skin does more than nudge one cell type; it appears to reshape the regenerative environment of the wound itself.
The cellular experiments sharpened the picture. In endothelial cells exposed to high glucose, with mannitol used as an osmotic control to separate sugar-specific effects from simple osmotic stress, restoring ITGA5 improved cell viability, migration, and tube formation. Conversely, knocking ITGA5 down aggravated the high glucose-induced endothelial dysfunction, increased mitochondrial reactive oxygen species accumulation, and worsened iron overload inside the mitochondria. In other words, the integrin seems to act as a brake on a destructive chain reaction in which damaged, iron-laden mitochondria poison the cells that need to build new blood vessels.
The mechanistic core of the paper lies in two connected pathways. First, ITGA5 activated the PI3K/AKT signaling pathway, which in turn reduced mitochondrial iron accumulation and lipid peroxidation, a hallmark of ferroptotic stress, and regulated iron metabolism-related proteins including the transferrin receptor TfR1, the iron exporter FPN1, and the storage protein Ferritin. When the researchers inhibited PI3K/AKT signaling, these protective effects were partially reversed, placing the pathway upstream of the iron-handling changes.
Second, and perhaps most strikingly, the study connected ITGA5 to mitocytosis, a recently described form of mitochondrial quality control in which cells package damaged mitochondria and expel them through migrasomes, small vesicle-like structures released by migrating cells. The authors report that ITGA5 promoted KIF5B-dependent mitochondrial transport to migrasomes, facilitating the expulsion of damaged mitochondria. When they knocked down KIF5B, the motor protein responsible for hauling mitochondria along microtubules, ITGA5-mediated mitochondrial protection was weakened, suggesting that the export route is a functional requirement rather than a bystander effect.
Taken together, the findings sketch a coherent model: in diabetic conditions, endothelial cells lose ITGA5, mitochondrial iron builds up, lipid peroxidation rises, and dysfunctional mitochondria accumulate because the KIF5B-dependent export route to migrasomes is not properly engaged. Restoring ITGA5 reactivates PI3K/AKT signaling, normalizes the expression of iron metabolism proteins, and re-enables the cellular garbage disposal system that keeps the mitochondrial network clean enough for angiogenesis to proceed.
The authors conclude that ITGA5 facilitates diabetic wound healing by preserving endothelial mitochondrial function through PI3K/AKT-mediated regulation of iron homeostasis and KIF5B-dependent mitochondrial export via migrasomes, and they highlight the molecule as a potential therapeutic target for diabetic foot ulcers. Because the work combines human tissue observations, a diabetic mouse model, and mechanistic cell experiments, it provides converging lines of evidence, though the gain- and loss-of-function manipulations were performed in preclinical and in vitro systems.
Subject of Research: How the integrin subunit ITGA5 regulates endothelial mitochondrial quality control and wound repair in diabetic foot ulcers
Article Title: ITGA5 accelerates diabetic wound healing by alleviating endothelial mitochondrial iron overload and promoting mitocytosis
Article References: Sun, Y., Yuan, L., Zhang, K., He, C., & Xiong, X. (2026). ITGA5 accelerates diabetic wound healing by alleviating endothelial mitochondrial iron overload and promoting mitocytosis. Journal of Translational Medicine. https://doi.org/10.1186/s12967-026-09130-w
Image Credits: AI Generated
DOI: 10.1186/s12967-026-09130-w
Keywords: diabetic foot ulcer, ITGA5, mitocytosis, migrasomes, endothelial dysfunction, mitochondrial iron overload, PI3K/AKT signaling, KIF5B, angiogenesis, wound healing, iron metabolism, db/db mice
News Source: Ophelia Keating. (November 7, 2026). ITGA5 speeds diabetic wound healing by easing mitochondrial iron overload. Scienmag.



